3. A new collaboration
Press Release | Wed Mar 18, 2015 2:24pm EDT
Assay Depot Creates Preclinical Innovation
Marketplace for AstraZeneca (AIM)
We have made the strategic decision that the AIM
platform will be the primary route for
AstraZeneca to do business with our preclinical
research suppliers in the future, Dapo Ajayi,
AstraZenecas Chief Procurement Officer.
Announcing the One Nucleus Assay Depot
collaboration!
23 June 2015 Launch seminar in Cambridge UK
with Assay Depot and AstraZeneca
4. One Nucleus at BIO2015
Sunday 14 June (6-9pm)
- Bio Executive Dinner
- The Moshulu
- 100 attendees for peer-to-peer networking
Monday 15 June (7-8am)
- SULS ON Roundtable Discussion
- Challenges in the development and
commercialisation of biomarkers
- Sonesta Hotel
Monday 15 June (8-10am)
- Polsinelli-UKTI-One Nucleus Breakfast &
Seminar
- A practical guide to entering the US market
- Sonesta Hotel
5. One Nucleus at BIO2015
Tuesday 16 June (9.30am)
- Signing of collaboration agreement with
Pennsylvania Bio
- PA Pavilion
Tuesday 16 June (11am 12pm)
- CEBR Medical Device Directory Launch
- European Commission Booth
Wednedsay 17 June (10.45am)
- Signing of Collaboration Agreement with BioNJ
- NJ Pavilion
7. www.onhelix.com
14 July 2015, Wellcome Trust Centre Cambridge, UK
One Nucleuss translational research conference
Keynote Address from Dr Bahija Jallal, Executive Vice
President AstraZeneca and Head of MedImmune
Sponsors include MedImmune, AstraZeneca, Horizon
and Abcam
250 BioPharma execs, scientists, investors and allied
professionals
8. www.genesisconference.com
10 December 2015, London, UK
650+ delegates for thought leadership debate from
sessions on:
-Case study deals
-Investment trends and strategy
-Technologies driving progress
-International growth strategies
60+ exhibitors, 1-2-1 partnering, BioNewsRound
Award and Fringe Events
Key sponsors: